Analyst Ratings for Alterity Therapeutics (ATHE)

ATHE Rating Summary

ATHE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ATHE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.67 (+383.5%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/15/2026 Lake Street Thomas Flaten New Coverage Buy
(N/A)
10.00
(N/A)
3.86
(2.62)
-32.12% Details
8/11/2026 Craig-Hallum Adam Vogel New Coverage Buy
(N/A)
12.00
(N/A)
83.33
(2.62)
-96.86% Details